Qube Research & Technologies LTD Astrazeneca PLC Transaction History

Qube Research & Technologies LTD

$65.7 Billion
Q3 2024

A detailed history of Qube Research & Technologies LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Qube Research & Technologies LTD holds 903,412 shares of AZN stock, worth $59.3 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

903,412

Previous 26,704 3283.06%

Holding current value

$59.3 Million

Previous $2.08 Million 3281.03%

% of portfolio

0.11%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $67.2 Million - $76.8 Million	876,708 Added 3283.06%	903,412 $70.4 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $4.07 Million - $4.92 Million	-60,877 Reduced 69.51%	26,704 $2.08 Million
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $53.7 Million - $61.2 Million	-879,473 Reduced 90.94%	87,581 $5.93 Million
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $55.4 Million - $62 Million	895,598 Added 1253.36%	967,054 $65.1 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $32.6 Million - $36 Million	-502,413 Reduced 87.55%	71,456 $4.84 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $5.19 Million - $5.62 Million	74,189 Added 14.85%	573,869 $41.1 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $1.12 Million - $1.27 Million	17,785 Added 3.69%	499,680 $34.7 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $6.87 Million - $8.92 Million	126,671 Added 35.66%	481,895 $32.7 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $18.8 Million - $48.2 Million	355,224 New	355,224 $19.5 Million
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $5.2 Million - $6.22 Million	-107,150 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $419,040 - $482,445	-7,896 Reduced 6.86%	107,150 $5.87 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $4.96 Million - $6.36 Million	115,046 New	115,046 $6.09 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $1.9 Million - $2.58 Million	-50,278 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $1.52 Million - $1.8 Million	35,719 Added 245.34%	50,278 $2.51 Million
Q3 2019 Nov 13, 2019	BUY	$40.12 - $45.47 $584,107 - $661,997	14,559 New	14,559 $649,000
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $248,345 - $266,315	-7,188 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$32.97 - $36.63 $236,988 - $263,296	7,188 New	7,188 $251,000

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Astrazeneca PLC Transaction History